| 0.1 |
0.5 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
1.0 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.2 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.1 |
1.2 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.1 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.0 |
0.6 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.1 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.0 |
0.2 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.0 |
0.2 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.0 |
0.3 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.1 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) sensory neuron axon guidance(GO:0097374) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.0 |
0.1 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.0 |
0.1 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.0 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
0.3 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.0 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.0 |
0.2 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.1 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.0 |
0.2 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.1 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 |
0.2 |
GO:0090292 |
nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.0 |
GO:0046671 |
negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.0 |
0.2 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.0 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
0.1 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
